thenewsfacts.com
  • Home
  • Latest News
  • Trending News
  • Entertainment
  • Technology
  • Sports
  • Business
  • Health
thenewsfacts.comthenewsfacts.com
Font ResizerAa
Search
  • Home
  • Latest News
  • Trending News
  • Entertainment
  • Technology
  • Sports
  • Business
  • Health
Follow US
© thenewsfacts : All Rights Reserved.

Home » Book Going Viral Now: The Inside Story of COVAXIN

Latest News

Book Going Viral Now: The Inside Story of COVAXIN

TheNewsFacts
Last updated: October 29, 2021 2:23 pm
TheNewsFacts
Share
Book Going Viral Now: The Inside Story of COVAXIN
SHARE

COVAXIN The Success of India’s Indigenous COVID-19 Vaccine developed by Bharat Biotech in partnership with ICMR and NIV Pune is a story to be told today. The Book Story of Covaxin, launched in Geneva according the author Dr. Balram Bhargava of ICMR , covers the entire journey not just of COVAXIN but also chronicles a bit of India’s fight against COVID 19 journey from the first case in January 2020.

The book launch was indeed a moment of pride for every India. The COVAXIN Book launch at the UNAIDS office in Geneva Thursday saw the presence of Dr Soumya Swaminathan, WHO chief scientist; Dr Mariangela Simao, WHO ADG Access to Medicines and Health Products; Nana Taona Kuo, Senior Health Adviser, Executive Office of the UN Secretary-General; and Puneet Agarwal, DPR Indian Mission to the UN in Geneva.

The process of granting EUL to Covaxin is being pushed from one meeting of the Technical Advisory Group (TAG) of WHO to its next — it was last taken up on 26 October and will again be considered on 3 November while the company has been submitting all the relevant information when asked and the review has been happening on a rolling basis.

According to ICMR officials, Dr Bhargava was in Geneva for a “health technology assessment meeting”.

The Inside Story of Covaxin, according to ICMR officials, covers the entire journey not just of Covaxin but also chronicles a bit of India’s Covid journey from the first case in January 2020.

The officials also stated that Dr Tedros Adhanom Ghebreyesus, WHO Director-General, was expected to be present at the event but he backed out because of the ongoing EUL tussle. “Whoever is saying Dr Tedros was to be present is probably related to the DG and has inside information that we are not aware of,” a senior ICMR official quoted.

The world is very interested in COVAXIN: The Book highlights the triumph of Made in India Vaccine by Bharat Biotech

COVAXIN - The inside story
The inside story of COVAXIN – Book by Dr. Balram Bhargava launched in Geneva

The adjuvant featured as a cover of the international science journal iScience so people are very inquisitive. There is a perception that killed virus vaccines do not work well but we have showed otherwise. That is why the launch happened in Geneva,” Dr Samiran Panda, head of epidemiology and communicable diseases at ICMR.

India’s Bharat Biotech has been submitting data on the EUL of Covaxin “regularly and very quickly” to a technical committee which hopes to have a final recommendation to the WHO next week, a top official of the global health agency said on Thursday, stressing that the UN body “trusts” the Indian industry that manufactures high quality vaccines

Epidemiologist Dr Ramanan Laxminarayan, founder of the Center for Disease Dynamics, Economics & Policy, Dr Bhargava said: “You asked about what we would have done differently. We know the vaccine needs BSLIII facility and scaling up was an issue… About 85% of the vaccines used in India were AstraZeneca. But we will now see more and more of Covaxin.”

“Let me say that Bharat has been submitting data regularly and very quickly, but they submitted the last batch of data on the 18th of October,” Dr Mariangela Simao, Assistant Director General, Access to Medicines and Health Products at WHO, said at a press briefing in Geneva.

She was responding to a question on the delay in granting the Emergency Use Listing to Covaxin while Chinese vaccines Sinopharm and Sinovac were given approval even “with lack of data.”

Simao said that when the technical advisory group met on October 26 to discuss the EUL for Covaxin, they asked Bharat Biotech for additional clarifications. The technical advisory group will reconvene on November 2 for the final risk-benefit assessment of Covaxin EUL.

She said WHO is in touch with Bharat Biotech and has “daily conversations” and calls and meetings “clarifying what additional data needs” to be submitted to the technical expert group.

TAGGED: Bharat Biotech, BHARAT BIOTECH COVAXIN, Covaxin, icmr dellhi
Share This Article
Twitter Email Copy Link Print
Previous Article Sabyasachi Lingerie ad was it meant to create controversy? Sabyasachi Lingerie ad was it meant to create controversy?
Next Article Generations will remember Puneeth Rajkumar for his iconic work - PM Modi Generations will remember Puneeth Rajkumar for his iconic work – PM Modi

Your Trusted Source for Accurate and Timely Updates!

We're committed to providing accurate and unbiased news as it unfolds, earning the trust of a large audience. Stay informed with our news updates on the latest events and trends, keeping you ahead of the curve.
FacebookLike
TwitterFollow
InstagramFollow

Popular Posts

Vizag Tech Summit 2023 announces INR 3000 Cr Projected Investments

The Vizag Tech Summit 2023 will be held on February 16th and 17th, 2023 which…

By TheNewsFacts

India’s Coal Ministry’s Mega Plan: 1404 MT by 2027, 1577 MT by 2030

In a bid to meet the escalating demand for power in the country, the Ministry…

By NewsFacts Bureau

Setback For Congress As Twitter Blocks Official Handle For Violations

Twitter has acted very tough with Twitter users who are violating rules. The impact has…

By TheNewsFacts

You Might Also Like

Bhool Chuk Maaf Box Office Report
Latest News

Bhool Chuk Maaf Crosses ₹54 Cr Globally in 7 Days

By NewsFacts Bureau
Bharat Biotech HILLCHOL
Latest News

Bharat Biotech’s Oral Cholera Vaccine HILLCHOL Demonstrates Success in Phase III Clinical Studies

By TheNewsFacts
Biovet Lumpy Skin Disease Vaccine Launched
Latest News

BIOLUMPIVAXIN: New Vaccine Now Available to Protect Livestock from LSD

By NewsFacts Bureau
Google AI First Accelerator 2025 India
Latest News

Google Opens 2025 India AI First Accelerator: $17B Opportunity for Startups

By NewsFacts Bureau
thenewsfacts thenewsfacts

About US


TheNewsFacts: Brings you the interesting facts, news facts and updates from India an the world across politics, tech, entertainment, business, tending, and more. We deliver what you love to read.
Top Categories
  • Latest News
  • Trending News
  • Paris Olympics 2024
  • Sports
  • Entertainment
  • Business
  • Technology
Usefull Links
  • About The News Facts
  • Latest News
  • Privacy Policy
  • Editorial Policy
  • Disclaimer
  • Contact Us
Follow us
Facebook Twitter Instagram

© thenewsfacts. All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?